Drug intelligence / Profile preview

2-aminobicyclo[2,2,1]heptane-2-carboxylic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
In Vitro (laboratory Research Use Only)
01

Overview

2-aminobicyclo[2,2,1]heptane-2-carboxylic acid is a **synthetic amino acid derivative** most commonly used as a **selective inhibitor of the large neutral amino acid transporter 1 (LAT1, also called "System L")**[1][2][5]. It competes for the transporter, blocking the cellular uptake of L-type amino acids such as L-leucine and L-dopa, making it a **tool compound** in transporter research and preclinical studies. BCH has shown utility in cancer research by suppressing LAT1-mediated amino acid uptake, leading to **antiproliferative and pro-apoptotic effects** in cancer cells[2][5]. It can also act as an **activator of the mitochondrial enzyme glutamate dehydrogenase (GDH)** in some research contexts[7]. Primary use is as a research tool compound, not a pharmaceutical.

Other names
2-amino-2-norbornanecarboxylic acid2-aminonorbornane-2-carboxylic acid2-Amino-2-carboxy-bicyclo-2,2,1-heptane3-amino-3-bicyclo[2.2.1]heptanecarboxylic acid3-aminobicyclo[2.2.1]heptane-3-carboxylic acid
02

Targets

GLUD1 (Glutamate dehydrogenase 1, mitochondrial)SLC7A5 (Large neutral amino acid transporter small subunit 1)

Beyond the preview

Go deeper on 2-aminobicyclo[2,2,1]heptane-2-carboxylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-aminobicyclo[2,2,1]heptane-2-carboxylic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call